Sojourn

Sojourn

sevoflurane

Manufacturer:

Piramal

Distributor:

Indochina Healthcare
Concise Prescribing Info
Contents
Sevoflurane
Indications/Uses
Induction & maintenance of general anesth in adult & childn.
Dosage/Direction for Use
Individualized dosage. Maintenance: 0.5-3% w/ or w/o nitrous oxide.
Contraindications
Hypersensitivity to other halogenated agents. Known or suspected susceptibility to malignant hyperthermia.
Special Precautions
Patients w/ latent & overt neuromuscular disease, particularly Duchenne muscular dystrophy. Risk of malignant hyperthermia may be increased in patients w/ hypersensitivity to volatile halogenated anesth agents; concomitant use w/ K hydroxide containing CO2 absorbents. Risk of seizures. Patients w/ underlying hepatic conditions or under treatment w/ drugs known to cause hepatic dysfunction. Premature infants. Pregnancy & lactation.
Adverse Reactions
Bradycardia, hypotension, tachycardia; agitation; laryngospasm, airway obstruction, breath holding, increased cough. Hypotension; apnea; increased salivation. Fever, shivering; hypothermia, movement, headache; HTN; somnolence, dizziness; nausea, vomiting.
Drug Interactions
Decreased anesth requirement w/ N2O. Exothermic reaction occurs w/ CO2 absorbents. Increase intensity & duration of neuromuscular blockade of non-depolarizing muscle relaxants.
MIMS Class
Anaesthetics - Local & General
ATC Classification
N01AB08 - sevoflurane ; Belongs to the class of halogenated hydrocarbons. Used as general anesthetics.
Presentation/Packing
Form
Sojourn inhalation vapour liqd 250 mL
Packing/Price
250 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in